Ocugen, Inc. (OCGN)
1.94
+0.12
(+6.59%)
USD |
NASDAQ |
Mar 02, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Ocugen EPS Diluted (Quarterly) : -0.066 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MannKind Corp. | -0.0519 |
| CorMedix, Inc. | 1.259 |
| Alector, Inc. | -0.3403 |
| Phathom Pharmaceuticals, Inc. | -0.2865 |
| Keros Therapeutics, Inc. | -0.1792 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.05M |
| Revenue (Quarterly) | 1.752M |
| Total Expenses (Quarterly) | 21.80M |
| Enterprise Value | 635.40M |
| Gross Profit Margin (Quarterly) | 45.78% |
| Profit Margin (Quarterly) | -1.14K% |
| Earnings Yield | -11.18% |
| Normalized Earnings Yield | -11.17 |